Treace Medical Concepts Inc (TMCI)

$5.81 +0.04 (0.69%)
Market Cap 362.88M
Revenue (ttm) 209.36M
Net Income (ttm) -55.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26.62%
Debt to Equity Ratio 0.51
Volume 208,800
Avg Vol 444,948
Day's Range N/A - N/A
Shares Out 62.89M
Stochastic %K 32%
Beta 0.68
Analysts Sell
Price Target $9.73

Latest News on TMCI

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

Jun 6, 2025, 9:11 AM EDT - 21 hours ago

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

Jun 5, 2025, 1:00 PM EDT - 1 day ago

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Jun 2, 2025, 1:09 PM EDT - 4 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

Jun 2, 2025, 9:50 AM EDT - 4 days ago

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

Treace Medical Concepts, Inc. (TMCI) Q1 2025 Earnings Call Transcript

May 11, 2025, 1:53 AM EDT - 27 days ago

Treace Medical Concepts, Inc. (TMCI) Q1 2025 Earnings Call Transcript

Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

May 9, 2025, 11:55 AM EDT - 4 weeks ago

Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

May 6, 2025, 11:54 AM EDT - 4 weeks ago

Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

May 3, 2025, 8:17 AM EDT - 4 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI

Apr 28, 2025, 12:33 PM EDT - 5 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 6 weeks ago

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Apr 19, 2025, 9:43 AM EDT - 6 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

Mar 28, 2025, 2:00 PM EDT - 2 months ago

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

Mar 25, 2025, 4:15 PM EDT - 2 months ago

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference